1. S100A4 contributes to colorectal carcinoma aggressive behavior and to chemoradiotherapy resistance in locally advanced rectal carcinoma.
- Author
-
Harada Y, Ikeda S, Kawabe Y, Oguri Y, Hashimura M, Yokoi A, Sida A, Fukagawa N, Hayashi M, Ono M, Kusano C, Takahashi H, and Saegusa M
- Subjects
- Humans, Male, Female, Middle Aged, HCT116 Cells, Aged, beta Catenin metabolism, Tumor Suppressor Protein p53 metabolism, Tumor Suppressor Protein p53 genetics, Prognosis, Cell Proliferation, Apoptosis, Adult, Neoadjuvant Therapy, Gene Expression Regulation, Neoplastic, S100 Calcium-Binding Protein A4 metabolism, S100 Calcium-Binding Protein A4 genetics, Rectal Neoplasms metabolism, Rectal Neoplasms pathology, Rectal Neoplasms therapy, Rectal Neoplasms genetics, Colorectal Neoplasms metabolism, Colorectal Neoplasms pathology, Colorectal Neoplasms genetics, Colorectal Neoplasms therapy, Chemoradiotherapy, Drug Resistance, Neoplasm
- Abstract
To investigate the functional role of S100A4 in advanced colorectal carcinoma (Ad-CRC) and locally advanced rectal carcinoma (LAd-RC) receiving neoadjuvant chemoradiotherapy (NCRT). We analyzed histopathological and immunohistochemical sections from 150 patients with Ad-CRC and 177 LAd-RC patients treated with NCRT. S100A4 knockout (KO) HCT116 cells were also used. S100A4 expression was absent in normal mucosa but increased progressively from colorectal adenoma to carcinoma, suggesting that S100A4 regulation is an early event in colorectal carcinogenesis. In Ad-CRC, high S100A4 expression correlated with high tumor budding and nuclear β-catenin, deep invasion, lymph-vascular involvement, and unfavorable prognosis. In NCRT-treated LAd-RC, high S100A4 expression was associated with poor treatment response and short progression-free survival. S100A4 KO decreased the proliferation of HCT116 cells through activation of the p53/p21
waf1 axis, and sensitized cells to adriamycin-induced apoptosis. Levels of the apoptotic marker, cleaved poly (ADP-ribose) polymerase 1, were significantly higher in samples with low S100A4 and wild type p53. Finally, we observed a direct interaction between S100A4 and p53. In conclusion, S100A4 expression engenders aggressive behavior in Ad-CRC through association with β-catenin-driven tumor buddings. S100A4 exerts anti-apoptotic and proliferative effects via inhibition of p53 in LAd-RC patients receiving NCRT, which leads to chemoradioresistance and poor prognosis., Competing Interests: Declarations. Competing interests: The authors declare no competing interests. Consent for publication: Not applicable. Ethics approval: This study was conducted in accordance with the principles expressed in the Declaration of Helsinki 1964 and later versions. This study was approved by the Kitasato University Medical Ethics Committee (B19-155). This article does not contain any studies with animals performed by any of the authors. Informed consent: was obtained from all subjects involved in the study., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF